Placebo (PO)
Placebo (PO) is a pharmaceutical drug with 8 clinical trials. Historical success rate of 62.5%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
62.5%
5 of 8 finished
37.5%
3 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19
Study to Evaluate the Safety and Tolerability of AMG 986 in Healthy Volunteers and Heart Failure Patients
Genetic Predictors of Analgesic Efficacy of Propranolol for Treating Postoperative Pain
Pilot Study of Sucrose to Reduce Pain in Sick Babies
Pain Response to Cannabidiol in Induced Acute Nociceptive Pain, Allodynia and Hyperalgesia By Using a Model Mimicking Acute Pain in Healthy Adults
Clinical Trials (8)
PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19
Study to Evaluate the Safety and Tolerability of AMG 986 in Healthy Volunteers and Heart Failure Patients
Genetic Predictors of Analgesic Efficacy of Propranolol for Treating Postoperative Pain
Pilot Study of Sucrose to Reduce Pain in Sick Babies
Pain Response to Cannabidiol in Induced Acute Nociceptive Pain, Allodynia and Hyperalgesia By Using a Model Mimicking Acute Pain in Healthy Adults
Effect on Pain of Oral Sucrose Versus Placebo in Children 1 to 3 Months Old Needing Venipuncture
Trial of an Oral Sucrose Solution Versus Placebo in Children 1 to 3 Months Old Needing Nasopharyngeal Aspiration
Trial of an Oral Sucrose Solution Versus Placebo in Children 1 to 3 Months Old Needing Bladder Catheterization
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8